BRCA1 and breast cancer: Our specific aims in the current study were (A) to identify a miR expression signature that could discriminate between familial and sporadic BC in young patients (≤35 years) who are non-carriers of BRCA1/2 mutations; and (B) to identify candidate target-genes related with the differentially expressed miRs.